LGM Pharma Expands U.S. CDMO Capacity and Navigates Reshoring, Supply-Chain Risks

24/7 Biopharma had the opportunity to sit down for a long-form interview about the state of the CDMO industry with Hamilton Lenox, Chief Commercial Officer, and Matt Grazioli, Senior Marketing Manager, of LGM Pharma. The discussion touched on LGM’s recent facility expansions, shifting market demands in the CDMO segment, and how the company is responding to the uncertain state of the global economy, among various other topics.

LATEST VIDEO

Latest news

27th October 2026

CordenPharma Achieves EcoVadis Gold Medal for Group-Wide Sustainability Performance

27th October 2026

Adalvo Expands Biosimilars Portfolio Through Acquisition of Romiplostim Biosimilar Programme from Enzene

27th October 2026

DFE Pharma appoints Peter Rose as new Chief Operating Officer

27th October 2026

Patrik Jonsson to retire after 36 years; Ilya Yuffa named president, Lilly Global Markets

27th October 2026

ProtaGene Appoints Former Merck KGaA CDMO Leader Matthias Bucerius as Chief Executive Officer

22nd October 2026

LGM Pharma Acquires Sannova Analytical, Expanding cGMP Analytical and GLP Bioanalytical Services

22nd October 2026

Lilly breaks ground in Richmond to expand American manufacturing of next-generation cancer medicines, advancing its build-out of 10 new U.S. sites since 2020

21st October 2026

EESTEVE CDMO STRENGTHENS ITS GLOBAL MANUFACTURING FOOTPRINT WITH A MAJOR INVESTMENT IN A NEW SITE IN CHINA

15th October 2026

Kindeva awarded up to $226 million contract to supply ATNAA autoinjectors to the Defense Logistics Agency

14th October 2026

Lonza Upgrades Organic Growth Model and Mid-term Financial Ambitions at Capital Markets Day; Q3 2026 In Line with Expectations

13th October 2026

Lonza Launches Enhanced DNA-to-IND Offering, Enabling IND Readiness in as Little as Six Months for More Complex Biologics

This week’s featured articles

Navigating Complexity: Industry Leaders on Bioprocessing, Manufacturing and Partnership Models

A woman’s view from the HAS Group

Breaking Barriers: Women Scientists Rising to Leadership in Pharma

Strategic Growth in Biologics Manufacturing: Insights from Lonza's Acquisition of the Vacaville Site

Grifols’ supply chain strategy offers lessons beyond saline

Partnered with top industry events and organisations